Abstract:
A shielding device and method for injecting a patient with radioactive material from a syringe to reduce exposure of workers to the radioactive material in the syringe. After the injection, the syringe needle falls away from the shield, thereby minimizing the risk of contamination of the shield from the contaminated syringe needle.
Abstract:
Memory security technologies are described. An example processing device includes a processor core and a memory controller coupled to the processor core and a memory. The processor core can determine that an exit condition to transfer control of a resource for a processor core from a first virtual machine monitor (VMM) to a second VMM has occurred. The processor core can also determine whether a control virtual machine control structure (VMCS) link pointer is valid. The processor core can also determine whether a reason value corresponding to the control VMCS link pointer is set. The processor core can also determine whether the reason value is set to zero. The processor core can also determining whether an exception bit corresponding to a specific exception type of a reason value is set. The processor core can also transfer a control of the resource from the first VMM to the second VMM.
Abstract:
Methods and apparatus are disclosed to capture error conditions in lightweight virtual machine managers. A disclosed example method includes defining a shared memory structure between the VMM and a virtual machine (VM), when the VM is spawned by the VMM, installing an abort handler on the VM associated with a vector value, in response to detecting an error, transferring VMM state information to the shared memory structure, and invoking the abort handler on the VM to transfer contents of the shared memory structure to a non-volatile memory.
Abstract:
A power tool having a depth adjustment mechanism includes a motor housing, a support base for supporting the motor housing, and a depth adjustment member coupled to the support base and movable between two positions. The depth adjustment member in a first position contacts a surface portion of the motor housing and in a second position is distanced from the surface portion of the motor housing such that the movement of the depth adjustment member from the first position to the second position is in a direction parallel to a plane that is substantially tangent to the surface portion of the motor housing.
Abstract:
A power tool having a depth adjustment mechanism includes a motor housing, a support base for supporting the motor housing, and a depth adjustment member coupled to the support base and movable between two positions. The depth adjustment member in a first position contacts a surface portion of the motor housing and in a second position is distanced from the surface portion of the motor housing such that the movement of the depth adjustment member from the first position to the second position is in a direction parallel to a plane that is substantially tangent to the surface portion of the motor housing.
Abstract:
Techniques are described for efficiently detecting and distinguishing among cardiac ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one example, a preliminary indication of an episode of cardiac ischemia is detected based on shifts in ST segment elevation within the IEGM. In response, the implanted device then records additional IEGM data for transmission to an external system. The external system analyzes the additional IEGM data to confirm the detection of cardiac ischemia using a more sophisticated analysis procedure exploiting additional detection parameters. In particular, the external system uses detection parameters capable of distinguishing hypoglycemia, hyperglycemia and hyperkalemia from cardiac ischemia, such as QTmax and QTend intervals. Alternatively, the more sophisticated analysis procedure may be performed by the device itself, if it is so equipped. Other examples described herein pertain instead to the detection of atrial fibrillation.
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.